RxDoctor Payments Data

Lisa Ebert

Family · Fremont, OHNPI 1588727135

Payments from drug & device makers

$211in general payments, 2019–2025

Across 13 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$44
  • Lilly USA, LLC$32
  • Biohaven Pharmaceuticals, Inc.$26
  • E.r. Squibb & Sons, L.L.C.$21
  • GSK$17
  • Abbott$16
  • plus $54 from 4 others

What the payments were for

  • Food & beverage$211100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$211 in reported general payments places this provider in the 40th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$41,749
Medicare patients
127
Services billed
706

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$51,128
EliquisApixaban56$42,818
JardianceEmpagliflozin36$28,145
JanuviaSitagliptin Phosphate14$12,440
XareltoRivaroxaban15$12,284
Breo ElliptaFluticasone/Vilanterol13$7,215
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,929
JanumetSitagliptin Phos/Metformin Hcl12$6,748
FarxigaDapagliflozin Propanediol11$6,293
Lisdexamfetamine Dimesylate17$4,283
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$4,231
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$3,438
BreynaBudesonide/Formoterol Fumarate22$3,315
Atorvastatin Calcium311$2,685
Omeprazole187$2,126

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$14$51,12845 claims
PfizerEliquis$12$42,81856 claims
GSKBreo Ellipta, Trelegy Ellipta$17$14,14424 claims
AbbVieSynthroid$44$1,20333 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 6,812 family providers in Ohio.

Other family in Fremont

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →